COMMUNIQUÉS West-GlobeNewswire

NeuroOne® CEO Dave Rosa Featured on Fox Business Network’s Varney & Co.
04/04/2024
EDEN PRAIRIE, Minn., April 04, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving surgical care options and [...]
Verana Health Developing Qdata® Dry Eye Disease, the Largest Real-World Dataset of its Kind
04/04/2024
Comprehensive real-world data on more than 10 million patients will help advance research and accelerate therapy development for dry eye disease and other ocular surface disorders SAN FRANCISCO, April 04, 2024 (GLOBE [...]
Progyny and RESOLVE to Honor National Infertility Awareness Week® with Events Spanning Coast to Coast
04/04/2024
The leading benefits solution and largest infertility advocacy non-profit will host a series of events aimed at raising awareness for the millions of individuals facing family building challenges NEW YORK, April 04, [...]
Altamira Therapeutics to Host Full Year 2023 Financial Results and Business Update Call on April 10, 2024
04/04/2024
Hamilton, Bermuda, April 04, 2024 (GLOBE NEWSWIRE) -- Altamira Therapeutics Ltd. ("Altamira" or the "Company") (Nasdaq: CYTO), a company providing nanoparticle-based technology for efficient RNA delivery to extrahepatic [...]
Over 52 Million Myeloma Warriors Reached, Creating Ripples Across the Globe for #MyelomaACTIONMonth
04/04/2024
2024 Myeloma Action Month Global Campaign Brings Wave of Myeloma Awareness to 36 Countries Worldwide STUDIO CITY, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- At the conclusion of this year’s Myeloma Action Month, the [...]
Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against Moderna
04/04/2024
WARMINSTER, Pa., April 04, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a functional cure for [...]
eFFECTOR Therapeutics Announces Topline Results of Phase 2 KICKSTART Trial of Tomivosertib Combined with Pembrolizumab in Non-Small Cell Lung Cancer
04/04/2024
SOLANA BEACH, Calif. and REDWOOD CITY, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader in the development of selective translation regulator inhibitors (STRIs) for the [...]
Carmell Announces $3.0 Million Private Placement
04/04/2024
PITTSBURGH, April 04, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health (“Carmell”, the “Company”, “we”, “our”, or “us”), today announced that it [...]
OrthoPediatrics Corp. to Highlight its Pediatric Scoliosis Solutions at 8th Annual International Children’s Spine Symposium (ICSS)
04/04/2024
WARSAW, Ind., April 04, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced it will attend [...]
BrainsWay Announces Published Review Results Highlighting Potential of Deep TMS™ to Treat Parkinson's Disease
04/04/2024
Clinical Data from Multiple Trials Showed Improvements in Both Motor and Non-Motor Symptoms JERUSALEM and BURLINGTON, Mass., April 04, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or [...]
Biora Therapeutics Achieves Positive Interim Results for Clinical Trial of BT-600, Advancing NaviCap™ Platform Development
04/04/2024
All pharmacokinetic endpoints were achieved, with a PK profile consistent with drug delivery and absorption in the colon All NaviCap™ devices performed as intended and were well tolerated, with no safety signals [...]
Recce Pharmaceuticals Granted New Patent in Israel for RECCE® Anti-Infectives
04/04/2024
SYDNEY, Australia, April 04, 2024 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q), the Company developing a new class of synthetic anti-infectives, today announced that the State of Israel Patent [...]
Central Georgia Cancer Care Joins American Oncology Network to Elevate Local Cancer Care Delivery
04/04/2024
MACON, Ga., April 04, 2024 (GLOBE NEWSWIRE) -- Central Georgia Cancer Care is excited to announce their partnership with the American Oncology Network (AON) (Nasdaq: AONC), one of the nation’s fastest-growing networks [...]
Tempest Announces Publication of Positive Data from Phase 1 Trial of TPST-1120 in Patients with Advanced Solid Tumors in Journal of Cancer Research Communications
04/04/2024
TPST-1120, a first-in-class, oral, selective PPAR⍺ antagonist, demonstrates clinical activity in PD-1 inhibitor refractory and immune compromised cancers Based on subsequent positive randomized data, Company preparing [...]
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/04/2024
WOBURN, Mass., April 04, 2024 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of a novel class of oncolytic immunotherapies, today announced [...]
Acumen Pharmaceuticals Collaborates with Lonza to Advance Sabirnetug for the Treatment of Alzheimer’s Disease
04/04/2024
Lonza to manufacture Acumen’s monoclonal antibody, sabirnetug (ACU193), for clinical development and commercialization, if approved Sabirnetug is the first monoclonal antibody candidate to enter the clinic developed to [...]
Ovid Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
04/04/2024
NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company dedicated to meaningfully improving the lives of people affected by rare epilepsies and brain conditions, [...]
Healthcare Triangle Announces Strategic Partnership with Cynomi to Enhance Cybersecurity in Healthcare
04/04/2024
PLEASANTON, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- Healthcare Triangle, Inc. (Nasdaq: HCTI) (“Healthcare Triangle,” “HCTI” or the “Company”), a leading provider of healthcare IT solutions, is thrilled to announce [...]
Extendicare Announces Timing of 2024 First Quarter Results and Conference Call
04/04/2024
MARKHAM, Ontario, April 04, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial results for the first quarter of 2024 after market [...]

Pages